España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Atara Biotherapeutics
ATRA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.11
-0.41
-5.45%
At close: -
$7.11
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Atara Biotherapeutics (ATRA) Forecast
News
Earnings
Atara Biotherapeutics (ATRA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Atara Biotherapeutics (NASDAQ:ATRA) Stock
Atara Biotherapeutics Stock (NASDAQ: ATRA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, January 28, 2025
HC Wainwright & Co. Reiterates Neutral on Ata...
Benzinga Newsdesk
Wednesday, January 22, 2025
HC Wainwright & Co. Reiterates Neutral on Ata...
Benzinga Newsdesk
Tuesday, January 21, 2025
FDA Places Clinical Hold On Atara Biotherapeutics' Two Cell Therapy Programs
Vandana Singh
FDA Places Clinical Hold On Atara Biotherapeu...
Benzinga Newsdesk
Friday, January 17, 2025
Canaccord Genuity Maintains Buy on Atara Biot...
Benzinga Newsdesk
Thursday, January 16, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Nasdaq Down 150 Points; Morgan Stanley Earnings Top Estimates
Avi Kapoor
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
Avi Kapoor
US Stocks Edge Lower; Retail Sales Increase Less Than Expected
Avi Kapoor
Atara Receives FDA CRL Citing Third-Party Man...
Benzinga Newsdesk
Trading Halt: Halted at 8:25:00 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, January 14, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Friday, December 20, 2024
Rodman & Renshaw Initiates Coverage On Atara ...
Benzinga Newsdesk
Wednesday, November 13, 2024
Atara Biotherapeutics shares are trading high...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Atara Biot...
Benzinga Newsdesk
Tuesday, November 12, 2024
Atara Biotherapeutics Q3 2024 GAAP EPS $(2.93...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Insights into Atara Biotherapeutics's Upcoming Earnings
Benzinga Insights
Tuesday, October 15, 2024
Atara Biotherapeutics Appoints Eric Hyllengre...
Benzinga Newsdesk
Wednesday, September 04, 2024
Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings
Avi Kapoor
Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On?
Henry Khederian
Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, September 03, 2024
Atara Biotherapeutics shares are trading high...
Benzinga Newsdesk
Atara Biotherapeutics Announces $36M Register...
Benzinga Newsdesk
Wednesday, August 21, 2024
HC Wainwright & Co. Reiterates Neutral on Ata...
Benzinga Newsdesk
Friday, August 16, 2024
Mizuho Upgrades Atara Biotherapeutics to Outp...
Benzinga Newsdesk
Tuesday, August 13, 2024
Canaccord Genuity Maintains Buy on Atara Biot...
Benzinga Newsdesk
Monday, August 12, 2024
Atara Biotherapeutics Expects Cash Runway Int...
Benzinga Newsdesk
Atara Biotherapeutics Q2 2024 GAAP EPS $(3.10...
Benzinga Newsdesk
Wednesday, July 17, 2024
Goldman Sachs Maintains Sell on Atara Biother...
Benzinga Newsdesk
Atara Biotherapeutics Receives FDA Acceptance...
Benzinga Newsdesk
Tuesday, June 18, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Monday, June 17, 2024
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Atara Biotherapeutics To Conduct 1-for-25 Rev...
Benzinga Newsdesk
Friday, May 31, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, May 29, 2024
Atara Biotherapeutics To Present Preclinical ...
Benzinga Newsdesk
Wednesday, May 22, 2024
HC Wainwright & Co. Reiterates Neutral on Ata...
Benzinga Newsdesk
Monday, May 20, 2024
Atara Biotherapeutics Submits Tabelecleucel B...
Benzinga Newsdesk
Thursday, May 09, 2024
Atara Biotherapeutics Q1 2024 GAAP EPS $(0.23...
Benzinga Newsdesk
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, April 08, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Monday, April 01, 2024
Stifel Maintains Hold on Atara Biotherapeutic...
Benzinga Newsdesk
Thursday, March 28, 2024
Atara Biotherapeutics Q4 EPS $(0.56) Misses $...
Benzinga Newsdesk
Atara Biotherapeutics: Q4 Earnings Insights
Benzinga Insights
Monday, March 18, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, March 08, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, March 06, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, February 29, 2024
Atara Biotherapeutics Receives FDA Clearance ...
Benzinga Newsdesk
Wednesday, February 14, 2024
Atara Biotherapeutics Announces Submission Of...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch